Extensive epidemiological evidence in humans and animal models suggests that poor maternal nutrition increases the susceptibility of the offspring to develop type-2 diabetes (T2D). The mechanisms by which adverse intrauterine environment increases the susceptibility to develop glucose intolerance and T2D are not well understood. However, current evidence supports the idea that a fetal nutrient environment induces long- term defects in -cell mass and function. How the fetal nutrient environment induces permanent changes in - cells and alters susceptibility to T2D is unknown. In the previous cycle, we discovered that protein restriction during pregnancy (LP) induces alterations in insulin secretion,increased susceptibility to glucolipotoxicity induced ER stress and impaired glucose tolerance by inducing the expression of a subset of microRNAs in islets from adult animals (mir-199 and mir-7). We also identified that these functional changes in -cells were associated to microRNA-mediated permanent reduction in mTOR and O-GlcNAc transferase (OGT) protein levels. The objective of this application is to build on these observations and assess how LP induces permanent changes in microRNA expression to regulate mTOR and OGT levels and susceptibility to diabetes. The central hypothesis to be tested is that protein insufficiency durin pregnancy alters insulin secretion and susceptibility to glucolipotoxicity-induced ER stress by regulating expression of mir-199 and mir-7 and their target genes mTOR and OGT respectively. These studies will determine first how LP acts on mir-199 and mir- 7 expression to regulate mTOR and OGT. Second, we will delineate how LP0.5 alters insulin secretion and - cell susceptibility to glucolipotoxicity. Finally, we will determine the extent to which different interventions during pregnancy rescue the metabolic and molecular abnormalities induced by LP0.5. These studies will enhance our understanding of the molecular mechanisms that govern the long-term consequences of the fetal environment on -cell mass and function. This information can be used to design novel therapeutic approaches to improve -cell mass and function in diabetics. Finally, understanding the pathophysiology of glucose intolerance observed in individuals with intrauterine growth retardation is important for both prevention and therapy.

Public Health Relevance

The mechanisms by which adverse intrauterine environment increases the susceptibility to develop glucose intolerance and type 2 diabetes are not well understood but a primary developmental insult to the -cell has been described. The goal of this application is to elucidate the how adverse nutrient environment during pregnancy induces permanent alterations in -cells in an effort to develop strategies to prevent diabetes in growth retarded fetuses and to identify pharmacological targets to improve -cell mass and function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK084236-05A1
Application #
8976520
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Sato, Sheryl M
Project Start
2009-07-01
Project End
2019-08-31
Budget Start
2015-09-15
Budget End
2016-08-31
Support Year
5
Fiscal Year
2015
Total Cost
$348,750
Indirect Cost
$123,750
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Navarro, Guadalupe; Allard, Camille; Morford, Jamie J et al. (2018) Androgen excess in pancreatic ? cells and neurons predisposes female mice to type 2 diabetes. JCI Insight 3:
Gregg, Brigid E; Botezatu, Nathalie; Brill, Joshua D et al. (2018) Gestational exposure to metformin programs improved glucose tolerance and insulin secretion in adult male mouse offspring. Sci Rep 8:5745
Blandino-Rosano, Manuel; Barbaresso, Rebecca; Jimenez-Palomares, Margarita et al. (2017) Loss of mTORC1 signalling impairs ?-cell homeostasis and insulin processing. Nat Commun 8:16014
Elghazi, Lynda; Blandino-Rosano, Manuel; Alejandro, Emilyn et al. (2017) Role of nutrients and mTOR signaling in the regulation of pancreatic progenitors development. Mol Metab 6:560-573
Alejandro, Emilyn U; Bozadjieva, Nadejda; Blandino-Rosano, Manuel et al. (2017) Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not ?-Cell Mass. Diabetes 66:2150-2162
Bozadjieva, Nadejda; Blandino-Rosano, Manuel; Chase, Jennifer et al. (2017) Loss of mTORC1 signaling alters pancreatic ? cell mass and impairs glucagon secretion. J Clin Invest 127:4379-4393
Cras-Méneur, Corentin; Conlon, Megan; Zhang, Yaqing et al. (2016) Early pancreatic islet fate and maturation is controlled through RBP-J?. Sci Rep 6:26874
Cras-Méneur, Corentin; Elghazi, Lynda; Fort, Patrice et al. (2016) Noninvasive in vivo imaging of embryonic ?-cell development in the anterior chamber of the eye. Islets 8:35-47
Blandino-Rosano, Manuel; Scheys, Joshua O; Jimenez-Palomares, Margarita et al. (2016) 4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls ?-Cell Mass. Diabetes 65:2235-48
Alejandro, Emilyn U; Bozadjieva, Nadejda; Kumusoglu, Doga et al. (2015) Disruption of O-linked N-Acetylglucosamine Signaling Induces ER Stress and ? Cell Failure. Cell Rep 13:2527-2538

Showing the most recent 10 out of 28 publications